In EMBO-02, NeoCast was evaluated in patients with chronic subdural hematoma (cSDH), a collection of blood on the surface of the brain, using middle meningeal artery embolization (MMAe).

Treatment with Next-Generation, Liquid Embolic NeoCast™ is Pain-Free and Leads to Rapid Resorption of Chronic Subdural Hematoma ...

Treatment with Next-Generation, Liquid Embolic NeoCast™ is Pain-Free and Leads to Rapid Resorption of Chronic Subdural Hematoma Late-Breaking Results from EMBO-02 Clinical Trial Presented at the ...

Early-stage cancer diagnosis potentially improves the chances of survival for many cancer patients worldwide. Manual examination of Whole Slide Images (WSIs) is a time-consuming task for analyzing ...

Background The safety of early anticoagulation in chronic subdural hematoma (cSDH) patients treated with surgery, with or without middle meningeal artery embolization (MMAE), remains unclear. This ...